Edwards Lifesciences to Present at the Canaccord Genuity Growth Conference
(firmenpresse) - IRVINE, CA -- (Marketwired) -- 08/12/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Canaccord Genuity Growth Conference 2013 on Wednesday, August 14, 2013. Thomas M. Abate, Edwards' corporate vice president and chief financial officer, is scheduled to speak to attendees at the InterContinental Boston at 2:30 p.m. EDT.
A live webcast will be available to all interested parties on the Edwards Lifesciences investor relations website at . Following the presentation, an archived version of the webcast will be available on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at .
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.
Media Contact:
Sarah Huoh
949-250-5070
Investor Contact:
David K. Erickson
949-250-6826
One Edwards Way
Irvine, CA USA 92614
Phone: 949.250.2500
Fax: 949.250.2525
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.08.2013 - 15:06 Uhr
Sprache: Deutsch
News-ID 1253875
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
IRVINE, CA
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 151 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Edwards Lifesciences to Present at the Canaccord Genuity Growth Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Edwards Lifesciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
